BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38484212)

  • 21. RNF213 gene mutation in circulating tumor DNA detected by targeted next-generation sequencing in the assisted discrimination of early-stage lung cancer from pulmonary nodules.
    Jiang N; Zhou J; Zhang W; Li P; Liu Y; Shi H; Zhang C; Wang Y; Zhou C; Peng C; Zhang W; Hao Y; Sun Q; Li Y; Zhao X
    Thorac Cancer; 2021 Jan; 12(2):181-193. PubMed ID: 33200540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care.
    Sheffield BS; Beharry A; Diep J; Perdrizet K; Iafolla MAJ; Raskin W; Dudani S; Brett MA; Starova B; Olsen B; Cheema PK
    Curr Oncol; 2022 Feb; 29(3):1326-1334. PubMed ID: 35323313
    [No Abstract]   [Full Text] [Related]  

  • 23. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
    Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prediction model for lung cancer diagnosis that integrates genomic and clinical features.
    Beane J; Sebastiani P; Whitfield TH; Steiling K; Dumas YM; Lenburg ME; Spira A
    Cancer Prev Res (Phila); 2008 Jun; 1(1):56-64. PubMed ID: 19138936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments.
    Coquerelle S; Darlington M; Michel M; Durand M; Borget I; Baffert S; Marino P; Perrier L; Durand-Zaleski I;
    Value Health; 2020 Jul; 23(7):898-906. PubMed ID: 32762992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patients.
    Francaviglia I; Magliacane G; Lazzari C; Grassini G; Brunetto E; Dal Cin E; Girlando S; Medicina D; Smart CE; Bulotta A; Gregorc V; Pecciarini L; Doglioni C; Cangi MG
    Lung Cancer; 2019 Aug; 134():225-232. PubMed ID: 31319985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.
    Maron SB; Chase LM; Lomnicki S; Kochanny S; Moore KL; Joshi SS; Landron S; Johnson J; Kiedrowski LA; Nagy RJ; Lanman RB; Kim ST; Lee J; Catenacci DVT
    Clin Cancer Res; 2019 Dec; 25(23):7098-7112. PubMed ID: 31427281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding next generation sequencing in oncology: A guide for oncologists.
    Moorcraft SY; Gonzalez D; Walker BA
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):463-74. PubMed ID: 26160606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice.
    R Teixeira M; Oliveira J; Borralho P; O Fernandes MG; Almodovar T; Fernandes I; Macedo D; Ferreira A; Barroso A; Teixeira E; Machado JC
    Acta Med Port; 2022 Sep; 35(9):677-690. PubMed ID: 35816050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of next-generation sequencing test for patients with advanced NSCLC in clinical practice.
    Ariyasu R; Uchibori K; Ninomiya H; Ogusu S; Tsugitomi R; Manabe R; Sakamaoto H; Tozuka T; Yoshida H; Amino Y; Kitazono S; Yanagitani N; Takeuchi K; Nishio M
    Thorac Cancer; 2021 Feb; 12(4):504-511. PubMed ID: 33350072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations.
    Choi YJ; Choi JY; Kim JW; Lim AR; Lee Y; Chang WJ; Lee S; Sung JS; Chung HJ; Lee JW; Kang EJ; Kim JS; Lim T; Kim HS; Kim YJ; Ahn MS; Kim YS; Park JH; Lim S; Cho SS; Cho JH; Shin SW; Park KH; Kim YH
    Cancer Res Treat; 2022 Jan; 54(1):30-39. PubMed ID: 34015890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer.
    Kruglyak KM; Lin E; Ong FS
    Adv Exp Med Biol; 2016; 890():123-36. PubMed ID: 26703802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next-Generation Sequencing in Lung Cancers-A Single-Center Experience in Taiwan.
    Lai WA; Huang YS; Chang KC; Yang SF; Yang CJ; Liu YW; Chen HD
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399524
    [No Abstract]   [Full Text] [Related]  

  • 35. Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients.
    Xi Y; Bai Z; Gao S; Guo J; Zhang Z; Zhang H; Qu L; Xu B; Wang W; Shan G; Cui W; Bai W; Ji X
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8573-8580. PubMed ID: 37186065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group.
    Malapelle U; Donne AD; Pagni F; Fraggetta F; Rocco EG; Pasello G; Perrone G; Pepe F; Vatrano S; Pignata S; Pinto C; Pruneri G; Russo A; Soto Parra HJ; Vallone S; Marchetti A; Troncone G; Novello S
    Crit Rev Oncol Hematol; 2024 Jan; 193():104217. PubMed ID: 38040072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United States.
    Bruno DS; Hess LM; Li X; Su EW; Patel M
    JCO Precis Oncol; 2022 Jun; 6():e2100427. PubMed ID: 35737912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker-Driven Studies With Multi-targets and Multi-drugs by Next-Generation Sequencing for Patients With Non-Small-Cell Lung Cancer: An Open-Label, Multi-center, Phase II Adaptive Umbrella Trial and a Real-World Observational Study (CTONG1702&CTONG1705).
    Liu SM; Yan HH; Wei XW; Lu C; Dong XR; Du Y; Cui JW; Chen Y; Ma R; Wang BH; Zhou Z; Cang SD; Yang JJ; Tu HY; Zhang XC; Zhong WZ; Zhou Q; Wu YL
    Clin Lung Cancer; 2022 Nov; 23(7):e395-e399. PubMed ID: 35659479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA.
    Thompson JC; Yee SS; Troxel AB; Savitch SL; Fan R; Balli D; Lieberman DB; Morrissette JD; Evans TL; Bauml J; Aggarwal C; Kosteva JA; Alley E; Ciunci C; Cohen RB; Bagley S; Stonehouse-Lee S; Sherry VE; Gilbert E; Langer C; Vachani A; Carpenter EL
    Clin Cancer Res; 2016 Dec; 22(23):5772-5782. PubMed ID: 27601595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas.
    Ezer N; Wang H; Corredor AG; Fiset PO; Baig A; van Kempen LC; Chong G; Issac MSM; Fraser R; Spatz A; Riviere JB; Broët P; Spicer J; Camilleri-Broët S
    Cancer Treat Res Commun; 2021; 29():100484. PubMed ID: 34773797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.